Thygesen Allan C.

CEO Thygesen sells 26,250 shares of DOCU for $1,254,161 (blended avg $47.78); holds 152,237 post-transaction

CEO Allan C. Thygesen executed 3 separate sales totaling 26,250 shares for $1,254,161.00 on April 1, 2026 at prices ranging from $46.44 to $48.12, reducing his holdings by 14.7%. The sales occur against a backdrop where DOCU trades at $48.37 current price, down 48.4% from its 52-week high of $93.84 but up 3.5% over the prior 30 days and down 25.4% over 90 days. His prior trades at DOCU (5 distinct transactions in the same-ticker history) show a 90-day well-timed rate of 2 of 2 measurable outcomes, suggesting pattern consistency, though the most recent 3 sales from January 2026 remain unmeasurable in their 90-day outcome. At the cross-ticker level, Thygesen's historical 90-day well-timed rate across all open-market sells stands at 58.82% with a modest +0.6% average 90-day return, indicating neither exceptional foresight nor a strong positive signal. The company's fundamentals remain solid: $818.4M quarterly revenue, +8.2% annual revenue growth, $83.7M net income, and a P/E of 31.61 in a $9.4B market-cap business.

DocuSign CEO Thygesen sells 26,250 shares for $1.8M at $69.60 avg; stock down -34.0% from 52-week high.

Thygesen executed 3 separate sales totaling 26,250 shares for $1,827,054.87 on 2026-01-09, reducing his holdings by 15.6% from 168,511 to 142,261 shares. The sales occurred at an average blended price of $69.60, though the current stock price is $64.51—roughly 7.3% below the transaction prices. DocuSign's stock has declined 34.0% from its 52-week high of $97.70 and 9.3% over the past 30 days, suggesting significant downward momentum at the time of and after this sale. Notably, Thygesen's prior 5 sales at DOCU show mixed timing results: 3 of the 5 prior transactions (60%) were followed by negative 90-day returns, indicating some pattern of selling before subsequent declines. However, the current stock price trading below the sale prices and the steep ytd decline merit close investor attention to underlying operational or market conditions.

DOCU CEO Thygesen sells 40,000 shares for $2.8M at $69.69 blended average; stock down -36.4% from 52-week high, -8.1% in 30 days

Allan C. Thygesen, President and CEO of DocuSign, sold 40,000 shares (22.7% of his pre-transaction holdings) across 4 separate sales totaling $2,787,428.28 on October 1, 2025, at prices ranging from $69.03 to $71.65. This sale occurred as DocuSign's stock has deteriorated substantially: it trades at $68.10, down 36.4% from its 52-week high of $106.99 and down 8.1% over the prior 30 days. Among Thygesen's 5 prior trades at DocuSign, 3 of the 5 prior sells exhibited well-timed outcomes at the 90-day mark, suggesting a demonstrated pattern of selling before or near declines at this specific ticker. With DocuSign trading at a 48.64 P/E against slowing growth of 7.8% annual revenue expansion and net income of $63.0M on $800.6M quarterly revenue, the timing of this large concentrated sale during an extended drawdown warrants attention to whether it reflects broader concerns about near-term momentum or execution.

DOCU CEO Thygesen sells 40,000 shares for $3.1M; stock down 13.5% in 30 days, 27.9% from 52-week high

Thygesen Allan C., President and CEO of DocuSign, executed 2 separate sales totaling 40,000 shares for $3,100,443.80 at a blended average price of $77.51, reducing his holdings by 21.7% from 184.0K to 144.0K shares. The timing of this substantial reduction is notable: DOCU has declined 13.5% over the past 30 days and trades 27.9% below its 52-week high of $106.99. Thygesen's prior 5 trades at DOCU show a pattern of well-timed sales—all 5 prior trades were well-timed at the 90-day mark with negative 90-day returns—suggesting the insider has consistently sold before subsequent declines. This sale, representing a material reduction of his equity stake and executed into a period of recent weakness, aligns with his historical pattern at this ticker.

CEO Allan C. Thygesen sells 40,000 DOCU shares for $3.3M at blended price $81.90; stock now -27.7% from 52-week high.

Allan C. Thygesen, President and CEO, executed 4 separate sales totaling 40,000 shares for $3,275,886.44 on 2025-04-01 at prices ranging from $80.34 to $82.91, disposing of 22.4% of his pre-transaction holdings. The timing is notable: these sales occurred near the stock's intermediate peak, as DocuSign has since declined 27.7% from its 52-week high of $106.99 and is trading 5.7% lower over the past month. Reviewing Thygesen's same-ticker history at DOCU, his 5 prior sales showed mixed timing outcomes—2 of 5 were well-timed at the 90-day mark, meaning the stock fell after those sales—while his cross-ticker track record shows a 50.00% well-timed sell rate with an average 90-day return of +2.4% (meaning the stock typically rose after his sales). The current sale's execution near elevated price levels, combined with the subsequent sharp pullback, aligns with patterns in his same-ticker history where prior December and January sales were followed by positive 30-day returns but mixed 90-day outcomes. Investors should note the significant insider reduction in CEO holdings during a period of stock weakness and reassess conviction around near-term catalysts.

DocuSign CEO Thygesen sells 40,000 shares for $3.6M on 2025-01-02; stock up 12.3% in 30 days, 41.5% in 90 days.

Thygesen conducted 2 separate sales totaling 40,000 shares for $3,601,780.08 at a blended average price of $90.04, reducing his holdings by 20.4% to 156,050 shares. The sales followed a strong momentum period: the stock had risen 12.3% over the prior 30 days and 41.5% over the prior 90 days, approaching its 52-week high of $106.99 before retreating to $90.35. In his cross-ticker track record, Thygesen's 6 prior open-market sells had a 90-day well-timed rate of 100.00%, though notably his prior sales at DocuSign itself show mixed timing—4 recent December and November 2024 sales posted 30-day gains of 10.0% to 13.9%, but his only measurable 90-day outcome at this ticker (2023-12-19 sale) returned -5.2%, indicating the stock declined after that earlier sale. The current transaction executed near the peaks of a strong recovery period, offering limited context for whether the CEO perceives value risk or is simply executing opportunistically at elevated prices.

DOCU CEO Thygesen sells 7,763 shares for $625,238.06 across 3 transactions on 2024-12-02

On 2024-12-02, Thygesen Allan C., President and CEO of DocuSign, executed 3 separate sales totaling 7,763 shares for $625,238.06 at prices ranging from $79.87 to $81.73, reducing his holdings by 7.2% to 100,062 shares. This transaction occurs during a period of strong stock performance: the 30-day return stands at +13.1% and the 90-day return at +40.1%, placing the current price of $80.45 only 5.9% below the 52-week high of $85.51. Notably, Thygesen's prior open-market trades at DocuSign show a pattern of well-timed selling, with 2 of 2 measurable prior sales followed by declines at the 90-day mark (most recent prior sale on 2024-11-01 showing 30d +13.9%), though his cross-ticker track record demonstrates mixed timing (average 90-day return of -5.6% across 3 prior sells). The company's fundamentals remain solid with annual revenue growth of +9.8%, a P/E of 16.52, and positive net income, providing no obvious fundamental distress signal accompanying this equity reduction.

DOCU CEO Thygesen sold 7,764 shares at $69.95 (Nov 1), retaining 107,825 shares; stock near 52-week highs despite -6.7% position reduction.

Allan C. Thygesen, President and CEO, sold 7,764 shares of DocuSign at $69.95 on 2024-11-01, generating $543,091.80 in proceeds while maintaining 107,825 shares post-sale. The transaction occurred with DOCU trading within 3.8% of its 52-week high of $72.60, and the stock has appreciated 38.1% over the prior 90 days. Notably, Thygesen's prior two sales at DocuSign (both on 2023-12-19) were well-timed at the 90-day mark, with negative returns of -5.2% and -6.0% respectively, matching his cross-ticker track record of 100% well-timed sells. However, the current transaction occurs near recent 52-week peaks and follows a strong 38.1% 90-day gain, suggesting this sale may not align with his established pattern of selling before subsequent declines.